标题:
Determining and Reducing Immunoresistance to a Botulinum Toxin Therapy Using Botulinum Toxin B Peptides
当前申请(专利权)人:
ALLERGAN, INC. AND BAYLOR COLLEGE OF MEDICINE
简单同族:
US20070280965A1 | US20070280966A1 | US20080118532A1 | US20100112609A1 | US20100112610A1 | US7691587 | US7855268 | US7968304